Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browsing publications by
Professor Nick Reynolds
Newcastle Authors
Title
Year
Full text
Dr Nina Wilson
Professor Nick Reynolds
Defining the therapeutic range for adalimumab and predicting response in psoriasis: amulticenter prospective observational cohort study
2019
Dr Henry Grantham
Professor Nick Reynolds
The devil is in the data: differences in drug persistence between SNIIRAM, the French national health insurance database, and psoriasis biologics intervention registers
2019
Professor Peter Farr
Professor Nick Reynolds
Dr Philip Hampton
Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies
2019
Professor Nick Reynolds
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis
2018
Professor Nick Reynolds
Clinical and genetic differences between pustular psoriasis subtypes
2018
Professor Nick Reynolds
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
2018
Professor Nick Reynolds
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2018
Professor Nick Reynolds
Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’”
2018
Professor Nick Reynolds
Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
2018
Tony Fouweather
Dr Deborah Stocken
Dr James Lloyd
Professor Peter Farr
Professor Nick Reynolds
et al.
An observer blinded randomised controlled pilot trial comparing localised immersion psoralen ultraviolet A (PUVA) with localised narrowband ultraviolet B (NBUVB) for the treatment of palmar hand eczema
2017
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19